Evidence map›Paper›PMID 31823124›Full record

ArticleMolecular biology reports2020

Protective effect of Nelumbo nucifera (Gaertn.) against H

Rajendran Harishkumar, Murugesan Susitra Manjari, Chellan Rose, Chinnadurai Immanuel Selvaraj

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Lotus seeds (Food science & nutrition · 2021
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Rajendran HarishkumarDepartment of Biotechnology, School of BioSciences and Technology, VIT School of Agricultural Innovations and Advanced Learning (VAIAL), VIT University, Vellore, Tamil Nadu, 632014, India.ORCID http://orcid.org/0000-0003-4038-6692
Murugesan Susitra ManjariDepartment of Biotechnology, CSIR-Central Leather Research Institute, Chennai, India.ORCID http://orcid.org/0000-0003-1154-0478
Chellan RoseDepartment of Biotechnology, CSIR-Central Leather Research Institute, Chennai, India.ORCID http://orcid.org/0000-0002-8321-2417
Chinnadurai Immanuel SelvarajDepartment of Biotechnology, School of BioSciences and Technology, VIT School of Agricultural Innovations and Advanced Learning (VAIAL), VIT University, Vellore, Tamil Nadu, 632014, India. immanuelselvaraj@vit.ac.in.ORCID http://orcid.org/0000-0001-5292-0122
Central Leather Research Institute · INVellore Institute of Technology University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemic heart disease (IHD), a severe condition of myocardium facing impediment in the supply of basic needs for cellular metabolism is caused by atherosclerosis. Though statin drugs could control the use of surgery on IHD patients, the complete rehabilitation or prophylaxis can be achieved through herbal-based medicines viz. either in the form of crude extract or pure phytocompounds. In the present study, pretreatment with leaf extract of Nelumbo nucifera Gaertn. was investigated for cardioprotective activity-in vitro by mitigating H

Indexed as

AnimalsAntioxidantsApoptosisBiomarkersCell LineCell SurvivalDNA FragmentationDose-Response Relationship, DrugHumansHydrogen PeroxideLipid PeroxidationMyocytes, CardiacNelumboOxidative StressPlant ExtractsReactive Oxygen SpeciesAntioxidantsBiomarkersHydrogen PeroxidePlant ExtractsReactive Oxygen SpeciesAntioxidantDNA fragmentationGene expressionH9c2 cardiomyocytesNelumbo nuciferaReactive oxygen species

Identifiers

PMID31823124
OpenAlexW2996351330

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.